Delivery Complication Clinical Trial
Official title:
Association Between Time of Oxytocin Initiation at 2nd Stage of Labor and Adverse Outcomes
Early oxytocin administration at the 2nd stage of labor is associated with a higher rate of vaginal delivery, shorter second stage duration, and fewer adverse maternal and neonatal outcomes.
Cesarean delivery (CD) is one of the most common surgeries performed worldwide. In the last few decades, its rate has steadily increased worldwide, leading to an increase in maternal morbidity and mortality compared to vaginal delivery (VD)1. In 2014, the American College of Obstetricians and Gynecologists (ACOG) and Society for Maternal Fetal Medicine (SMFM) published an Obstetric Care Consensus for safe prevention of primary cesarean delivery, allowing an additional hour of pushing during the 2nd stage of labor for both nulliparous and multiparous women before diagnosing prolonged 2nd of labor2-4. Prolonged 2nd stage is especially common among nulliparous women5, and is defined as more than three hours of pushing6, or four hours for women with a regional anesthesia. Prolonged 2nd stage has been shown to be associated with maternal adverse outcomes, such as assisted-vaginal delivery, CD, and postpartum hemorrhage (PPH)7,8, and neonatal adverse outcomes such as low 5-minute Apgar score, and NICU admissions9. Oxytocin is the primary and the most widely used pharmacological agent for induction and augmentation of labor10. Administrating oxytocin during labor is a common practice and is used to intensify contractions and decrease the chances of a non-progressive labor and associated adverse outcomes11,12. Despite its extensive use, there are several protocols which varies between different countries and obstetric wards. Likewise, there is no consensus regarding the duration or dosage of oxytocin infusion during labor, and especially during the 2nd stage of labor13. The study will assess the optimal time initiation of Oxytocin during the 2nd stage of labor, and its association to mode of delivery, and adverse maternal and neonatal outcomes. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03730220 -
The Norwegian Induction Project: a Pilot for a Prospective National Audit
|
||
Completed |
NCT05047211 -
Intravenous Iron vs. Oral Iron Supplementation for Postpartum Anemia
|
Phase 4 | |
Completed |
NCT04181840 -
Impedance Spectroscopy for Obstetric Anal Sphincter Injuries Detection
|
N/A | |
Not yet recruiting |
NCT05080309 -
Effect of Oral Carbohydrate Intake > 44kCal Per Hour During Labour on the Rate of Instrumental Vaginal Delivery
|
N/A | |
Completed |
NCT06002997 -
Periodontal Status and Pregnancy or Delivery Complications in Type 1 Diabetes Mellitus Pregnant Women
|
||
Completed |
NCT04903977 -
Detection of Obstetric Anal Sphincter Injuries With ONIRY Device
|
N/A | |
Recruiting |
NCT05345600 -
MILTA vs Placebo Use Comparison for the Management of Pain Related to Perineal Scars Following Delivery
|
N/A | |
Completed |
NCT05605626 -
Learning Skills in Young Specialists and Residents in Operative Vaginal Delivery Using Simulator Models
|
||
Not yet recruiting |
NCT06411158 -
Training for Urinary Leakage Improvement After Pregnancy
|
N/A | |
Not yet recruiting |
NCT05845879 -
Obstetrical Outcomes for Planned Deliveries in a French Birth Center
|
||
Completed |
NCT05579808 -
Effect of Epidural Analgesia on Labour, Neonatal and Maternal Outcomes.
|
||
Completed |
NCT03161184 -
Impact of a Smartphone Intervention on Tanzanian Women's Childbirth Location
|
N/A | |
Recruiting |
NCT04159857 -
Hand Forceps vs. Conventional One-hand Technique for Fetal Head Extraction During Cesarean Section
|
N/A | |
Recruiting |
NCT04685668 -
The PartoMa Project: Enabling Best Post Possible Childbirth Care in Tanzania.
|
N/A | |
Completed |
NCT04796155 -
Intrapartum Ultrasonography in Labour Arrest
|
||
Completed |
NCT05258786 -
Pre-labor Ultrasound as a Visual Biofeedback Device for Maternal Pushing Education
|
N/A | |
Completed |
NCT04664335 -
Impact of Endometriosis on Pregnancy and Delivery - a Retrospective Cohort Study
|
||
Not yet recruiting |
NCT05079061 -
A Trial of Sublingual Misoprostol to Reduce Primary Postpartum Haemorrhage After Vaginal Delivery
|
Phase 4 |